Author Archives: Thomas Payne

TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones

By

TScan Therapeutics Announces Upcoming Presentations at the 25th American Society of Gene and Cell Therapy Annual Meeting

By

TScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance

By

TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities

By

TScan Therapeutics to Participate in Upcoming Investor Conferences

By

TScan Therapeutics Announces Presentation at the 11th Annual SVB Leerink Global Healthcare Conference

By

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies

By

TScan Outlines 2022 Priorities as Programs Enter Clinic

By

TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition

By

TScan Therapeutics to Host a Virtual Event to Discuss Highlights from the 63rd ASH Annual Meeting and Exposition

By